Clinical Trial Update: A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating DNTH103 in adults with generalized myasthenia gravis is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• DNTH103

Snippet

Sponsor: Dianthus Therapeutics | Conditions: Myasthenia Gravis, Generalized | Phase 2 | Status: ACTIVE_NOT_RECRUITING